Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02867605 · ClinicalTrials.gov registry record · NA
Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02867605 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 20 participants.
The verdict
NCT02867605, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether oral HA35 supplementation changes the normal intestinal bacteria, increases intestinal protection, decrease intestinal inflammation and permeability, and to assess any health benefits and confirm the safety profile of HA35.
Interventions
- DIETARY_SUPPLEMENT Hyaluronan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02867605
The ClinicalTrials.gov registry entry for NCT02867605 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyaluronan is the first listed.
NCT02867605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02867605 about?
NCT02867605 is a clinical study titled "Human Pilot Study - HA35 (Hyaluronan Molecular Weight 35) Dietary Supplement for Promoting Intestinal Health". The purpose of this study is to evaluate whether oral HA35 supplementation changes the normal intestinal bacteria, increases intestinal protection, decrease intestinal inflammation and permeability, and to assess any health benefits and confirm the safety profile of HA35.
What is the current status of trial NCT02867605?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-07. Estimated completion is 2019-06-20.
What interventions are being tested in trial NCT02867605?
The interventions under investigation include: Hyaluronan (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02867605?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.